Progress in HER2-Positive Gastroesophageal Adenocarcinoma

(MedPage Today) -- After a period of relative inactivity, therapeutic development in HER2-positive gastroesophageal adenocarcinoma (GEA) has evolved rapidly over the past 5 years, establishing a new standard of care that was supplanted by another...